State Street’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $287M | Buy |
8,649,766
+169,767
| +2% | +$5.06M | 0.01% | 773 |
|
|
2025
Q4 | $253M | Buy |
8,479,999
+379,380
| +5% | +$12.4M | 0.01% | 820 |
|
|
2025
Q3 | $293M | Buy |
8,100,619
+482,381
| +6% | +$15.9M | 0.01% | 750 |
|
|
2025
Q2 | $274M | Buy |
7,618,238
+184,339
| +2% | +$6.86M | 0.01% | 745 |
|
|
2025
Q1 | $293M | Sell |
7,433,899
-1,766,009
| -19% | -$59.4M | 0.01% | 697 |
|
|
2024
Q4 | $277M | Buy |
9,199,908
+105,750
| +1% | +$3.03M | 0.01% | 750 |
|
|
2024
Q3 | $213M | Buy |
9,094,158
+2,398,015
| +36% | +$52.4M | 0.01% | 888 |
|
|
2024
Q2 | $119M | Sell |
6,696,143
-1,100,436
| -14% | -$17.6M | 0.01% | 1160 |
|
|
2024
Q1 | $119M | Sell |
7,796,579
-456,994
| -6% | -$7.28M | 0.01% | 1199 |
|
|
2023
Q4 | $141M | Sell |
8,253,573
-1,564,049
| -16% | -$18.2M | 0.01% | 1066 |
|
|
2023
Q3 | $82.1M | Buy |
9,817,622
+4,189,436
| +74% | +$58.4M | ﹤0.01% | 1312 |
|
|
2023
Q2 | $140M | Sell |
5,628,186
-2,015,619
| -26% | -$52.1M | 0.01% | 1008 |
|
|
2023
Q1 | $115M | Sell |
7,643,805
-2,771,356
| -27% | -$42.1M | 0.01% | 1089 |
|
|
2022
Q4 | $123M | Sell |
10,415,161
-1,335,239
| -11% | -$9.69M | 0.01% | 1043 |
|
|
2022
Q3 | $69.6M | Sell |
11,750,400
-2,484,863
| -17% | -$16.3M | ﹤0.01% | 1362 |
|
|
2022
Q2 | $60.5M | Buy |
14,235,263
+4,606,679
| +48% | +$28.8M | ﹤0.01% | 1502 |
|
|
2022
Q1 | $91.6M | Buy |
9,628,584
+3,804,406
| +65% | +$44M | ﹤0.01% | 1352 |
|
|
2021
Q4 | $111M | Buy |
5,824,178
+1,527,426
| +36% | +$39.7M | 0.01% | 1226 |
|
|
2021
Q3 | $143M | Buy |
4,296,752
+684,605
| +19% | +$21.2M | 0.01% | 1022 |
|
|
2021
Q2 | $140M | Buy |
3,612,147
+352,866
| +11% | +$13.9M | 0.01% | 1055 |
|
|
2021
Q1 | $157M | Sell |
3,259,281
-453,561
| -12% | -$21.8M | 0.01% | 912 |
|
|
2020
Q4 | $193M | Sell |
3,712,842
-396,277
| -10% | -$13.4M | 0.01% | 761 |
|
|
2020
Q3 | $110M | Sell |
4,109,119
-918,008
| -18% | -$21.1M | 0.01% | 914 |
|
|
2020
Q2 | $97.9M | Buy |
5,027,127
+1,532,474
| +44% | +$24.7M | 0.01% | 977 |
|
|
2020
Q1 | $34.4M | Buy |
3,494,653
+89,348
| +3% | +$1.13M | ﹤0.01% | 1499 |
|
|
2019
Q4 | $37.8M | Sell |
3,405,305
-505,419
| -13% | -$3.84M | ﹤0.01% | 1710 |
|
|
2019
Q3 | $22M | Sell |
3,910,724
-1,319,257
| -25% | -$9.2M | ﹤0.01% | 2005 |
|
|
2019
Q2 | $45.2M | Buy |
5,229,981
+1,953,015
| +60% | +$14.8M | ﹤0.01% | 1546 |
|
|
2019
Q1 | $26.3M | Sell |
3,276,966
-1,065,652
| -25% | -$5.76M | ﹤0.01% | 1872 |
|
|
2018
Q4 | $17.8M | Buy |
4,342,618
+206,901
| +5% | +$1.03M | ﹤0.01% | 2071 |
|
|
2018
Q3 | $23.2M | Buy |
4,135,717
+423,614
| +11% | +$4.84M | ﹤0.01% | 2079 |
|
|
2018
Q2 | $48.8M | Buy |
3,712,103
+593,842
| +19% | +$8.17M | ﹤0.01% | 1507 |
|
|
2018
Q1 | $44.3M | Sell |
3,118,261
-293,405
| -9% | -$3.75M | ﹤0.01% | 1497 |
|
|
2017
Q4 | $28M | Buy |
3,411,666
+159,201
| +5% | +$1.39M | ﹤0.01% | 1828 |
|
|
2017
Q3 | $38.5M | Buy |
3,252,465
+613,782
| +23% | +$6.99M | ﹤0.01% | 1551 |
|
|
2017
Q2 | $26.5M | Buy |
2,638,683
+1,933,896
| +274% | +$21.6M | ﹤0.01% | 1796 |
|
|
2017
Q1 | $8.21M | Buy |
704,787
+25,672
| +4% | +$184K | ﹤0.01% | 2462 |
|
|
2016
Q4 | $3.16M | Buy |
679,115
+42,760
| +7% | +$251K | ﹤0.01% | 2912 |
|
|
2016
Q3 | $4.92M | Buy |
636,355
+12,048
| +2% | +$77.5K | ﹤0.01% | 2573 |
|
|
2016
Q2 | $3.78M | Sell |
624,307
-556,731
| -47% | -$4.53M | ﹤0.01% | 2763 |
|
|
2016
Q1 | $10.1M | Buy |
1,181,038
+39,117
| +3% | +$342K | ﹤0.01% | 2169 |
|
|
2015
Q4 | $13.6M | Sell |
1,141,921
-1,493,102
| -57% | -$18.9M | ﹤0.01% | 1999 |
|
|
2015
Q3 | $26.6M | Buy |
2,635,023
+542,774
| +26% | +$8.09M | ﹤0.01% | 1558 |
|
|
2015
Q2 | $34.7M | Buy |
2,092,249
+424,565
| +25% | +$6.72M | ﹤0.01% | 1483 |
|
|
2015
Q1 | $25.8M | Buy |
1,667,684
+1,311,768
| +369% | +$19.9M | ﹤0.01% | 1668 |
|
|
2014
Q4 | $5.64M | Buy |
355,916
+84,524
| +31% | +$1.1M | ﹤0.01% | 2504 |
|
|
2014
Q3 | $2.9M | Buy |
271,392
+48,749
| +22% | +$452K | ﹤0.01% | 2824 |
|
|
2014
Q2 | $2.09M | Buy |
222,643
+13,656
| +7% | +$87.3K | ﹤0.01% | 3051 |
|
|
2014
Q1 | $1.44M | Buy |
208,987
+66,433
| +47% | +$393K | ﹤0.01% | 3177 |
|
|
2013
Q4 | $558K | Sell |
142,554
-13,210
| -8% | -$53.4K | ﹤0.01% | 3347 |
|
|
2013
Q3 | $793K | Buy |
155,764
+97,833
| +169% | +$598K | ﹤0.01% | 3285 |
|
|
2013
Q2 | $371K | Buy |
+57,931
| New | +$371K | ﹤0.01% | 3274 |
|
Other funds holding TGTX
VPM
VCM
SCM
CAM
State Street's TGTX Position: Q1 2026 in Review
State Street increased its TG Therapeutics (TGTX) stake by 2% in Q1 2026, buying an estimated $5.06M and bringing the position to 8,649,766 shares worth $287M. The position accounts for 0.01% of the portfolio, ranked #773.
State Street first reported a position in TGTX in Q2 2013 and has held it in 52 quarters since. The position peaked at $293M in Q1 2025. 363 funds tracked by Wall St. Rank hold TGTX as of Q1 2026.
- State Street held 8,649,766 shares of TG Therapeutics worth $287M as of Q1 2026.
- State Street bought 169,767 TG Therapeutics shares in Q1 2026, an estimated $5.06M.
- TG Therapeutics made up 0.01% of State Street's portfolio in Q1 2026, its #773 holding.
- State Street first reported a position in TG Therapeutics in Q2 2013 and has held it in 52 quarters since.
- State Street's TG Therapeutics position peaked at $293M in Q1 2025.
- 363 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2026.
Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.